# Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

> **NCT01825200** · PHASE3 · COMPLETED · sponsor: **Protein Sciences Corporation** · enrollment: 2640 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Flublok
- **BIOLOGICAL:** Afluria

## Key facts

- **NCT ID:** NCT01825200
- **Lead sponsor:** Protein Sciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 2640 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825200, "Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01825200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*